Literature DB >> 12709717

Ensuring access to essential medicines in the developing countries: a framework for action.

Jonathan D Quick1.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12709717     DOI： 10.1016/s0009-9236(03)00002-x

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  18 in total

1.  Price differentiation and transparency in the global pharmaceutical marketplace.

Authors:  David B Ridley
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  WHO Essential Medicines List for Children: impact on patient outcomes?

Authors:  Andy Gray
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

3.  Government use licenses in Thailand: an assessment of the health and economic impacts.

Authors:  Inthira Yamabhai; Adun Mohara; Sripen Tantivess; Kakanang Chaisiri; Yot Teerawattananon
Journal:  Global Health       Date:  2011-08-14       Impact factor: 4.185

4.  Availability of medicines in public sector health facilities of two North Indian States.

Authors:  Shankar Prinja; Pankaj Bahuguna; Jaya Prasad Tripathy; Rajesh Kumar
Journal:  BMC Pharmacol Toxicol       Date:  2015-12-23       Impact factor: 2.483

5.  Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all.

Authors:  Anita Kotwani
Journal:  BMC Health Serv Res       Date:  2013-07-25       Impact factor: 2.655

6.  Towards equitable access to medicines for the rural poor: analyses of insurance claims reveal rural pharmacy initiative triggers price competition in Kyrgyzstan.

Authors:  Brenda Waning; Jason Maddix; Yorghos Tripodis; Richard Laing; Hubert Gm Leufkens; Manjusha Gokhale
Journal:  Int J Equity Health       Date:  2009-12-14

7.  Improving access to medicines in low and middle income countries: corporate responsibilities in context.

Authors:  Klaus Michael Leisinger; Laura Faden Garabedian; Anita Katharina Wagner
Journal:  South Med Rev       Date:  2012-12-27

8.  Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study.

Authors:  Laura Faden Garabedian; Dennis Ross-Degnan; Sauwakon Ratanawijitrasin; Peter Stephens; Anita Katharina Wagner
Journal:  BMJ Open       Date:  2012-11-28       Impact factor: 2.692

9.  Deficient supplies of drugs for life threatening diseases in an African community.

Authors:  Norman N Lufesi; Marit Andrew; Ivar Aursnes
Journal:  BMC Health Serv Res       Date:  2007-06-15       Impact factor: 2.655

10.  Measuring Equity in Access to Pharmaceutical Services Using Concentration Curve; Model Development.

Authors:  Majid Davari; Elahe Khorasani; Zahra Bakhshizade; Marzie Jafarian Jazi; Mohsen Ghaffari Darab; Mohammad Reza Maracy
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.